Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer

被引:107
作者
Fiorentino, Michelangelo [1 ]
Zadra, Giorgia [1 ]
Palescandolo, Emanuele [1 ]
Fedele, Giuseppe [1 ]
Bailey, Dyane [1 ]
Fiore, Christopher [1 ]
Nguyen, Paul L. [1 ]
Migita, Toshiro [1 ]
Zamponi, Raffaella [1 ]
Di Vizio, Dolores [2 ]
Priolo, Carmen [1 ]
Sharma, Chandan [3 ]
Xie, Wanling [4 ]
Hemler, Martin E. [2 ]
Mucci, Lorelei [5 ]
Giovannucci, Edward [5 ]
Finn, Stephen [1 ]
Loda, Massimo [1 ]
机构
[1] Brigham & Womens Hosp, Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Dept Med Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Childrens Hosp, Dept Urol, Boston, MA USA
[3] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA
[5] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Brigham & Womens Hosp,Channing Lab, Boston, MA 02115 USA
关键词
beta-catenin; fatty acid synthase; prostate cancer; immunohistochemistry; palmitoylation; Wnt1;
D O I
10.1038/labinvest.2008.97
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Fatty acid synthase (FASN), a key metabolic enzyme for liponeogenesis highly expressed in several human cancers, displays oncogenic properties such as resistance to apoptosis and induction of proliferation when overexpressed. To date, no mechanism has been identified to explain the oncogenicity of FASN in prostate cancer. We generated immortalized prostate epithelial cells (iPrECs) overexpressing FASN, and found that C-14-acetate incorporation into palmitate synthesized de novo by FASN was significantly elevated in immunoprecipitated Wnt-1 when compared to isogenic cells not overexpressing FASN. Overexpression of FASN caused membranous and cytoplasmic beta-catenin protein accumulation and activation, whereas FASN knockdown by short-hairpin RNA resulted in a reduction in the extent of beta-catenin activation. Orthotopic transplantation of iPrECs overexpressing FASN in nude mice resulted in invasive tumors that overexpressed beta-catenin. A strong significant association between FASN and cytoplasmic ( stabilized) beta-catenin immunostaining was found in 862 cases of human prostate cancer after computerized subtraction of the membranous beta-catenin signal (P < 0.001, Spearman's rho = 0.33). We propose that cytoplasmic stabilization of beta-catenin through palmitoylation of Wnt-1 and subsequent activation of the pathway is a potential mechanism of FASN oncogenicity in prostate cancer.
引用
收藏
页码:1340 / 1348
页数:9
相关论文
共 43 条
[1]   20-year outcomes following conservative management of clinically localized prostate cancer [J].
Albertsen, PC ;
Hanley, JA ;
Fine, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17) :2095-2101
[2]   Body size and prostate cancer: A 20-year follow-up study among 135006 Swedish construction workers [J].
Andersson, SO ;
Wolk, A ;
Bergstrom, R ;
Adami, HO ;
Engholm, G ;
Englund, A ;
Nyren, O .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (05) :385-389
[3]   FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis [J].
Bandyopadhyay, S ;
Pai, SK ;
Watabe, M ;
Gross, SC ;
Hirota, S ;
Hosobe, S ;
Tsukada, T ;
Miura, K ;
Saito, K ;
Markwell, SJ ;
Wang, Y ;
Huggenvik, J ;
Pauza, ME ;
Iiizumi, M ;
Watabe, K .
ONCOGENE, 2005, 24 (34) :5389-5395
[4]   Fatty acid synthase: A metabolic oncogene in prostate cancer? [J].
Baron, A ;
Migita, T ;
Tang, D ;
Loda, M .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 91 (01) :47-53
[5]   Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells [J].
Berger, R ;
Febbo, PG ;
Majumder, PK ;
Zhao, JJ ;
Mukherjee, S ;
Signoretti, S ;
Campbell, KT ;
Sellers, WR ;
Roberts, TM ;
Loda, M ;
Golub, TR ;
Hahn, WC .
CANCER RESEARCH, 2004, 64 (24) :8867-8875
[6]   Expression of β-catenin in prostatic adenocarcinomas -: A comparison with colorectal adenocarcinomas [J].
Bismar, TA ;
Humphrey, PA ;
Grignon, DJ ;
Wang, HLL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (04) :557-563
[7]   Inactivation of Apc in the mouse prostate causes prostate carcinoma [J].
Bruxvoort, Katia J. ;
Charbonneau, Holli M. ;
Giambernardi, Troy A. ;
Goolsby, James C. ;
Qian, Chao-Nan ;
Zylstra, Cassandra R. ;
Robinson, Daniel R. ;
Roy-Burman, Pradip ;
Shaw, Aubie K. ;
Buckner-Berghuis, Bree D. ;
Sigler, Robert E. ;
Resau, James H. ;
Sullivan, Ruth ;
Bushman, Wade ;
Williams, Bart O. .
CANCER RESEARCH, 2007, 67 (06) :2490-2496
[8]   Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638
[9]   Up-regulation of Wnt-1 and β-catenin production in patients with advanced metastatic prostate carcinoma -: Potential pathogenetic and prognostic implications [J].
Chen, GP ;
Shukeir, N ;
Potti, A ;
Sircar, K ;
Aprikian, A ;
Goltzman, D ;
Rabbani, SA .
CANCER, 2004, 101 (06) :1345-1356
[10]   In vitro evidence for complex modes of nuclear β-catenin signaling during prostate growth and tumorigenesis [J].
Chesire, DR ;
Ewing, CM ;
Gage, WR ;
Isaacs, WB .
ONCOGENE, 2002, 21 (17) :2679-2694